Oriyomi Alimi is a Fellow with F-Prime Capital with a focus on investments in therapeutics and medical device companies. Dr. Alimi has worked in the healthcare sector as a clinical pharmacist in the retail, health plan and hospital settings. Last year as graduating medical student, he completed the Howard Hughes Medical Fellowship where he investigated the pharmacokinetics and pharmacodynamics of a humanized monoclonal antibody against a novel target.

Dr. Alimi completed his M.D. from Yale School of Medicine May of 2020 and is currently a general surgery resident at Yale New Haven Hospital. He received his Pharm.D. from University of Pittsburgh